COVID-19

Pharma industry slams WTO move on TRIPS waiver

Pharma industry slams WTO move on TRIPS waiver

By Jane Byrne

Pharma industry organizations say they are deeply disappointed by the decision taken by World Trade Organization (WTO) at its ministerial conference, MC12, to endorse a TRIPS waiver for COVID-19 vaccines.

Pic:getty/maxiphoto

Catalent buys UK vaccine manufacturing centre

By Rachel Arthur

US company Catalent is acquiring the UK’s Vaccine Manufacturing and Innovation Centre in Harwell: a facility which had been planned to support COVID-19 and wider vaccine production and which is still under construction.

© GettyImages/Cecilie_Arcurs

Novartis inks contract manufacturing deal with Carisma

By Jane Byrne

Novartis continues down the third-party manufacturing route, as it secures an agreement with Carisma Therapeutics, a firm developing a cell therapy platform focused on engineered macrophage-based therapeutics.

Pic:getty/tosheo

EU nears decision on Novavax COVID-19 vaccine

By Rachel Arthur

The European Medicines Agency (EMA) could issue an opinion on Novavax’ Conditional Marketing Authorization for its COVID-19 vaccine ‘within weeks’.

© GettyImages/VectorFusionArt

Special Edition: BioPharma Hubs

Dublin set to get a life sciences incubation and acceleration cluster

By Jane Byrne

A new specialized lab, office and collaboration space for over 100 life science and health technology professionals, entrepreneurs, and researchers was recently announced for The Campus, Cherrywood in South Dublin, Ireland.

Follow us

Products

View more

Webinars